Point72 Hong Kong’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$3.77K | – | 597 |
|
|
2024
Q4 | $3.77K | Buy |
+200
| New | +$3.77K | ﹤0.01% | 363 |
|
|
2022
Q3 | – | Sell |
-788
| Closed | -$46K | – | 1767 |
|
|
2022
Q2 | $46K | Sell |
788
-2,706
| -77% | -$158K | ﹤0.01% | 942 |
|
|
2022
Q1 | $267K | Buy |
3,494
+1,746
| +100% | +$133K | 0.01% | 418 |
|
|
2021
Q4 | $105K | Buy |
1,748
+1,656
| +1,800% | +$99.5K | ﹤0.01% | 620 |
|
|
2021
Q3 | $5K | Sell |
92
-6,530
| -99% | -$355K | ﹤0.01% | 1240 |
|
|
2021
Q2 | $402K | Buy |
+6,622
| New | +$402K | 0.01% | 448 |
|
|
2021
Q1 | – | Sell |
-847
| Closed | -$51K | – | 1575 |
|
|
2020
Q4 | $51K | Buy |
+847
| New | +$51K | ﹤0.01% | 750 |
|
|
2020
Q3 | – | Sell |
-2,706
| Closed | -$142K | – | 1431 |
|
|
2020
Q2 | $142K | Buy |
+2,706
| New | +$142K | 0.02% | 562 |
|
|
2019
Q4 | – | Sell |
-1,239
| Closed | -$47K | – | 1377 |
|
|
2019
Q3 | $47K | Buy |
1,239
+735
| +146% | +$27.9K | 0.01% | 589 |
|
|
2019
Q2 | $22K | Buy |
504
+493
| +4,482% | +$21.5K | 0.01% | 764 |
|
|
2019
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 1214 |
|
|
2018
Q3 | – | Sell |
-90
| Closed | -$3K | – | 1105 |
|
|
2018
Q2 | $3K | Sell |
90
-231
| -72% | -$7.7K | ﹤0.01% | 748 |
|
|
2018
Q1 | $10K | Sell |
321
-1
| -0.3% | -$31 | 0.01% | 694 |
|
|
2017
Q4 | $15K | Buy |
322
+212
| +193% | +$9.88K | 0.01% | 428 |
|
|
2017
Q3 | $4K | Buy |
110
+89
| +424% | +$3.24K | ﹤0.01% | 594 |
|
|
2017
Q2 | $1K | Sell |
21
-910
| -98% | -$43.3K | ﹤0.01% | 726 |
|
|
2017
Q1 | $42K | Buy |
+931
| New | +$42K | 0.05% | 273 |
|